NCT02866695View on ClinicalTrials.gov

Safety and Efficacy of Ingenol Mebutate Gel 0.015% for Treatment of AK on the Face in Solid Organ Transplant Recipients

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 6, 2016

Primary Completion Date

July 2, 2018

Study Completion Date

July 2, 2018

Conditions

Actinic Keratosis

Interventions

DRUG

ingenol mebutate gel 0.015%

ingenol mebutate gel 0.015% to be applied on treatment area

Trial Locations (1)

94115

UCSF Dermatology, San Francisco

All Listed Sponsors

lead

University of California, San Francisco

OTHER

NCT02866695 - Safety and Efficacy of Ingenol Mebutate Gel 0.015% for Treatment of AK on the Face in Solid Organ Transplant Recipients | Biotech Hunter | Biotech Hunter